PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsOpening A New Clinic
Pathology and Laboratory Medicine
Product Catalogue

​Recombinant Coagulation Factor VIII Concentrate

Transfusion Medicine

​Alternate Product Names
  • Adynovate
  • Factor VIII Concentrate
  • Eloctate (Patient Designated Plasma Protein Products Request must be submitted)
  • Kovaltry
  • Nuwiq
  • Xyntha
​Indications
  • ​Prevention and control of bleeding episodes in patients with congenital factor VIII deficiency (Hemophilia A)
​Resource Information

​Product Monographs:

Extended Half-Life Factor VIII Product::

Standard Half-Life Factor VIII Products:

Product Information
Size/Volume Available
  • Adynovate

                  Volumes Available: 250 II, 500 IU, 1000 IU, 2000 IU

  • Eloctate

            Volumes Available:  500 IU, 1000 IU

  • Kovaltry

                  Volumes Available:  250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU

  • Nuwiq

     Volumes Available: 500 IU, 1000 IU

  • Xyntha

                  Volumes Available:  250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU 

 

  • Products not listed may be available through Canadian Blood Services by contacting Transfusion Medicine or your site laboratory
Availability
​RUH​SCH​SPH​Rural
​Yes​No​No​Contact your site laboratory
  • ​SCH and SPH requests will be transported from RUH as requests are received
Pretransfusion Testing Requirements
  • ​None required
Forms Required

​Saskatoon:

Rural:

  • Contact your site laboratory
Home infusion program:
Ordering
  • Specify type of coagulation concentrate and dosage required
  • Off label requests for anyone other than bleeding disorders patients must be approved by the Transfusion Medicine Medical Physician
​Notes
​Administration
  • ​See Notes
  • Factor VIII Concentrate does not contain human protein; informed patient consent not required for this product

 

​If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-55 v6

Last Modified: Thursday, February 7, 2019 |
Questions or feedback about this page?